Select your Region     
Therapeutic Strategies in Lipid Disorders

Price: £49.99
Foreword by:
Eugene Braunwald M.D.
Distinguished Hersey Professor of Medicine Harvard Medical School
& Chairman, TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts, USA.

1. A global view of cardiovascular risk factors, CK Chow, A Patel
2. LDL cholesterol as a therapeutic target, J Armitage, L Bowman
3. HDL cholesterol as a therapeutic target, P Barter, K-A Rye
4. Apolipoprotein B in the therapy of atherogenic dyslipoproteinaemias, A Sniderman
5. Management of coronary heart disease patients, KK Ray, CP Cannon
6. Stroke and transient ischaemic attack prevention, P Amarenco, PC Lavallée, M Mazighi, J Labreuche
7. Diabetes and the metabolic syndrome, A Cameron, J Shaw, P Zimmet, AM Tonkin
8. Hypertension, R Grimm
9. Treatment of familial hypercholesterolaemia, R Huijgen, HJ Avis, BA Hutten, MN Vissers, JJP Kastelein
10. Lipid lowering in chronic kidney disease, V Perkovic, M Jardine, M Gallagher, A Cass
11. Statins and heart failure, J Kjekshus
12. Absolute risk assessment in the general population, L Chen, AM Tonkin
13. Pleiotropic effects of statins and other possible indications, J Davignon, H Wassef
14. The role of imaging endpoints in clinical trials, SJ Nicholls
15. Biomarkers in cardiovascular disease, S Blankenberg, R Schnabel
16. Novel lipid-modifying agents, EA Stein, K Kostner, D Sullivan
17. Translating the evidence base into improved outcomes, AM Tonkin

General Index

Privacy Policy | Terms and Conditions of Sale